NCT02171455View on ClinicalTrials.gov

Safety, Pharmacodynamics and Pharmacokinetics After Single Oral Administration of Dabigatran Etexilate Capsule in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

January 31, 2006

Conditions
Healthy
Interventions
DRUG

Dabigatran etexilate low dose

DRUG

Dabigatran etexilate medium dose

DRUG

Dabigatran etexilate high dose

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY